Y-chromosome markers in Turner syndrome: Screening of 130 patients

Journal of Endocrinological Investigation

Volumn 33, Issue 4, 2010, Pages 222-227

  Sallai, A ^a   Solyom J ^a   Dobos, M ^a   Szabo J ^a   Halasz Z ^a   Sagodi L ^b   Niederland, T ^c   Kozari A ^d   Bertalan, R ^e   Ugocsai, P ^f   Fekete, G ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Borsod County Teaching Hospital   (Hungary)

^c Endocrinology and Diabetology   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

^e Csolnoky Ferenc County Hospital   (Hungary)

^f Test Tube Baby Foundation   (Hungary)

Author keywords

Gonadoblastoma; Real time PCR; Turner syndrome; Y chromosome

Indexed keywords

DNA; GENETIC MARKER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; CYTOGENETICS; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GONADECTOMY; GONADOBLASTOMA; HUMAN; HUMAN TISSUE; INFANT; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; METAPHASE; POPULATION RESEARCH; PRESCHOOL CHILD; PROPHYLAXIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SCREENING; TURNER SYNDROME; Y CHROMOSOME; FEMALE; GENETIC MARKER; GENETICS; HUNGARY; NEWBORN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, Y; CYTOGENETIC ANALYSIS; FEMALE; GENETIC MARKERS; GONADOBLASTOMA; HUMANS; HUNGARY; INFANT; INFANT, NEWBORN; KARYOTYPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TURNER SYNDROME; YOUNG ADULT;

EID: 77953571592     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03345783     Document Type: Article

References (30)

1. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004, 351: 1227-38.
2. Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural Y abnormalities or mosaicism. Hum Genet 1983, 64: 24-7.
3. Magenis RE, Breg WR, Clark KA. Distribution of sex chromosome complements in 651 patients with Turner's syndrome. Am J Hum Genet 1980, 32: 79A.
4. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenetics 1987, 25: 191-218.
5. Lindgren V, Chen C, Bryke CR, Lichter P, Page DC, Yang-Feng TL. Cytogenetic and molecular characterization of marker chromosomes in patients with mosaic 45,X karyotypes. Hum Genet 1992, 88: 393-8.
6. Manuel M, Katayama PK, Jones HW Jr. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 1976, 124: 293-300.
7. Mazzanti L, Cicognani A, Baldazzi L, et al. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A 2005, 135: 150-4.
8. Magtibay PM. Treatment, behavior and prognosis of gonadoblastoma. CME J Gynecol Oncol 2004, 9: 26-7.
9. Cools M, Drop SLS, Wolffenbuttel KP, Oosterhuis JW, Looijenga LHJ. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006, 27: 468-84.
10. Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006, 118: e488-500.
11. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995, 57: 1400-7.
12. Hildenbrand R, Schröder W, Brude E, et al. Detection of TSPY protein in an unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol 1999, 189: 623-6.
13. Lau YF. Gonadoblastoma, testicular and prostate cancers, and TSPY gene. Am J Hum Genet 1999, 64: 921-7.
14. Delbridge ML, Longepied G, Depetris D, et al. TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution. Chromosome Res 2004, 12: 345-56.
15. Ball TB, Plummer FA, HayGlass KT. Improved mRNA quantitation in LightCycler RT-PCR. Int Arch Allergy Immunol 2003, 130: 82-6.
16. Wilkening S, Bader A. Quantitative real-time polymerase chain reaction: methodical analysis and mathematical model. J Biomol Tech 2004, 5: 107-11.
17. Haltrich I, Müller J, Szabó J, et al. Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 2003, 142: 124-8.
18. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 1986, 83: 2934-8.
19. Chu CE, Connor JM, Donaldson MDC, Kelnar CJH, Smail PJ, Greene SA. Detection of Y mosaicism in patients with Turner's syndrome. J Med Genet 1995, 32: 578-80.
20. Quilter CR, Taylor K, Conway GS, Nathwani N, Delhanty JDA. Cytogenetic and molecular investigations of Y chromosome sequences and their role in Turner syndrome. Ann Hum Genet 1998, 62: 99-106. (Pubitemid 28412359)
21. Gravholt CH, Fedder J, Naeraa RW, Müller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000, 85: 3199-202.
22. Álvarez-Nava F, Soto M, Sánchez MA, Fernández E, Lanes R. Molecular analysis in Turner syndrome. J Pediatr 2003,142: 336-40.
23. Canto P, Kofman-Alfaro S, Jiménez AL, et al. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences. Cancer Genet Cytogenet 2004, 150: 70-2.
24. McDonough PG, Tho SPT. Clinical implications of overt and cryptic Y mosaicism in individuals with dysgenetic gonads. In: Gravholt CH, Bondy CA, eds. Wellness for Girls and Women with Turner Syndrome: International Congress Series 1298, Amsterdam: Elsevier 2006, 13-20.
25. Hovatta O, Hreinsson J, Fridström M, Borgström B. Fertility and pregnancy aspects in Turner syndrome. In: Gravholt CH, Bondy CA, eds. Wellness for Girls and Women with Turner Syndrome: International Congress Series 1298, Amsterdam: Elsevier 2006, 185-9.
26. Page DC. Y chromosome sequences in Turner's syndrome and risk of gonadoblastoma or virilisation. Lancet 1994, 343: 240.
27. Bianco B, Lipay MV, Melaragno MI, Guedes AD, Verreschi ITN. Detection of hidden Y mosaicism in Turner's syndrome: importance in the prevention of gonadoblastoma. J Pediatr Endocrinol Metab 2006, 19: 1113-7.
28. Giltay JC, Ausems MG, van Seumeren I, et al. Short stature as the only presenting feature in a patient with an isodicentric (Y)(q11.23) and gonadoblastoma. A clinical and molecular cytogenetic study. Eur J Pediatr 2001, 60: 154-8.
29. Osipova GR, Karmanov ME, Kozlova SI, Evgrafov OV. PCR detection of Y specific sequences in patients with Ullrich-Turner syndrome: clinical implications and limitations. Am J Med Genet 1998, 76: 283-7.
30. Vodicka R, Vrtel R, Scheinost O, et al. Refined quantitative fluorescent PCR of Y-chromosome DNA sequences mosaics in Turner's syndrome patients-alternative to real-time PCR. J Biochem Biophys Methods 2004, 60: 151-62.